BR0113011A - Novos compostos e sua utilização como inibidores de transporte de glicina; composição farmacêutica e método do tratamento - Google Patents

Novos compostos e sua utilização como inibidores de transporte de glicina; composição farmacêutica e método do tratamento

Info

Publication number
BR0113011A
BR0113011A BR0113011-0A BR0113011A BR0113011A BR 0113011 A BR0113011 A BR 0113011A BR 0113011 A BR0113011 A BR 0113011A BR 0113011 A BR0113011 A BR 0113011A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
treatment method
novel compounds
transport inhibitors
compounds
Prior art date
Application number
BR0113011-0A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of BR0113011A publication Critical patent/BR0113011A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/58—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and singly-bound nitrogen atoms, not being further bound to other hetero atoms, bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/72—Benzo[c]thiophenes; Hydrogenated benzo[c]thiophenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Abstract

"NOVOS COMPOSTOS E SUA UTILIZAçãO COMO INIBIDORES DE TRANSPORTE DE GLICINA; COMPOSIçãO FARMACêUTICA E MéTODO DO TRATAMENTO". A invenção provê novos compostos da fórmula I abaixo: (I), onde o significado de cada substituto é conforme o definido no pedido. Os compostos são úteis como inibidores do transportador de glicina e úteis no tratamento de doenças que apresentam resposta à inibição do transportador de glicina. A invenção provê uma composição farmacêutica compreendendo um composto de Fórmula I conforme o definido acima e a utilização de compostos conforme acima para a fabricação de medicamentos para o tratamento de doenças que apresentam resposta aos ligandos do transportador de glicina.
BR0113011-0A 2000-07-21 2001-07-19 Novos compostos e sua utilização como inibidores de transporte de glicina; composição farmacêutica e método do tratamento BR0113011A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001124 2000-07-21
PCT/DK2001/000510 WO2002008216A1 (en) 2000-07-21 2001-07-19 Novel compounds and their use as glycine transport inhibitors

Publications (1)

Publication Number Publication Date
BR0113011A true BR0113011A (pt) 2003-07-01

Family

ID=8159626

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0113011-0A BR0113011A (pt) 2000-07-21 2001-07-19 Novos compostos e sua utilização como inibidores de transporte de glicina; composição farmacêutica e método do tratamento

Country Status (28)

Country Link
US (1) US6921774B2 (pt)
EP (1) EP1301502B1 (pt)
JP (1) JP2004504393A (pt)
KR (1) KR20030015889A (pt)
CN (1) CN100509791C (pt)
AR (1) AR032358A1 (pt)
AT (1) ATE295844T1 (pt)
AU (2) AU2001281740B2 (pt)
BG (1) BG107530A (pt)
BR (1) BR0113011A (pt)
CA (1) CA2416447A1 (pt)
CZ (1) CZ2003396A3 (pt)
DE (1) DE60110914T2 (pt)
EA (1) EA005621B1 (pt)
ES (1) ES2238466T3 (pt)
HR (1) HRP20030053A2 (pt)
HU (1) HUP0302778A3 (pt)
IL (2) IL153988A0 (pt)
IS (1) IS6693A (pt)
MX (1) MXPA03000642A (pt)
NO (1) NO20030243L (pt)
NZ (1) NZ523720A (pt)
PL (1) PL364439A1 (pt)
PT (1) PT1301502E (pt)
SK (1) SK2022003A3 (pt)
UA (1) UA75081C2 (pt)
WO (1) WO2002008216A1 (pt)
ZA (1) ZA200300514B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006524642A (ja) * 2003-04-30 2006-11-02 ハー・ルンドベック・アクチエゼルスカベット 芳香族オキシフェニルおよび芳香族スルファニルフェニル誘導体
US20060223857A1 (en) * 2003-08-21 2006-10-05 Michael Didriksen Combination of a serotonin reuptake inhibitor and a glycine transporter type 1 inhibitor for the treatment of depression
US7163954B2 (en) * 2003-09-25 2007-01-16 Wyeth Substituted naphthyl benzothiophene acids
JP2007528879A (ja) * 2004-03-12 2007-10-18 ハー・ルンドベック・アクチエゼルスカベット フェニルインダン誘導体
WO2005100301A1 (en) * 2004-03-31 2005-10-27 Eli Lilly And Company 2-aryloxyethyl glycine derivatives and their use as glycine transport inhibitors
WO2006000222A2 (en) * 2004-06-24 2006-01-05 H. Lundbeck A/S The combination of an antipsychotic and a glycine transporter type i inhibitor for the treatment of schizophrenia
EP2042480B1 (en) 2006-07-18 2013-05-01 Astellas Pharma Inc. Aminoindan derivative or salt thereof
KR101097533B1 (ko) * 2006-08-30 2011-12-22 에프. 호프만-라 로슈 아게 Ｇｌｙｔ-1 억제제
US20100083581A1 (en) * 2007-06-18 2010-04-08 Mattice Douglas A Environmental brush seal
ES2615884T3 (es) 2009-01-20 2017-06-08 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Ácido sórbico y benzoico y sus derivados que aumentan la actividad de un neurofármaco
EP2380595A1 (en) 2010-04-19 2011-10-26 Nlife Therapeutics S.L. Compositions and methods for selective delivery of oligonucleotide molecules to specific neuron types
US9700563B2 (en) * 2012-09-06 2017-07-11 MediSynergies, LLC Kappa opioid receptor compounds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1166711A (en) * 1966-03-28 1969-10-08 Kefalas As Process for the Preparation of Phenyl-Indane and -Tetralin Derivatives
US3549656A (en) 1967-12-28 1970-12-22 Kefalas As Antidepressant 1 - aminoalkyl - thiophthalanes and acid addition salts thereof
GB1526331A (en) * 1976-01-14 1978-09-27 Kefalas As Phthalanes
US5225323A (en) 1988-11-21 1993-07-06 Baylor College Of Medicine Human high-affinity neurotransmitter uptake system
WO1993010228A1 (en) 1991-11-12 1993-05-27 Synaptic Pharmaceutical Corporation Dna encoding a glycine transporter and uses thereof
US5824486A (en) 1996-05-31 1998-10-20 Allelix Neuroscience Inc. Glycine transporter-transfected cells and uses thereof
US6008015A (en) 1997-04-11 1999-12-28 Allelix Neuroscience Inc. Glycine transporter
AR021509A1 (es) * 1998-12-08 2002-07-24 Lundbeck & Co As H Derivados de benzofurano, su preparacion y uso
AR021155A1 (es) * 1999-07-08 2002-06-12 Lundbeck & Co As H Tratamiento de desordenes neuroticos
US6566550B2 (en) * 2001-06-21 2003-05-20 Pfizer Inc Substituted aromatic ethers as inhibitors of glycine transport

Also Published As

Publication number Publication date
EP1301502B1 (en) 2005-05-18
NO20030243L (no) 2003-03-06
DE60110914T2 (de) 2005-10-27
CZ2003396A3 (cs) 2003-05-14
AU2001281740B2 (en) 2006-02-16
EA005621B1 (ru) 2005-04-28
IL153988A0 (en) 2003-07-31
IS6693A (is) 2003-01-20
EP1301502A1 (en) 2003-04-16
DE60110914D1 (de) 2005-06-23
PT1301502E (pt) 2005-09-30
ZA200300514B (en) 2004-08-20
NO20030243D0 (no) 2003-01-17
ES2238466T3 (es) 2005-09-01
JP2004504393A (ja) 2004-02-12
NZ523720A (en) 2004-07-30
HUP0302778A3 (en) 2005-02-28
ATE295844T1 (de) 2005-06-15
AU8174001A (en) 2002-02-05
US20030181445A1 (en) 2003-09-25
UA75081C2 (en) 2006-03-15
MXPA03000642A (es) 2003-06-06
HUP0302778A2 (hu) 2003-12-29
BG107530A (bg) 2003-09-30
HRP20030053A2 (en) 2005-02-28
US6921774B2 (en) 2005-07-26
EA200300180A1 (ru) 2003-06-26
CA2416447A1 (en) 2002-01-31
KR20030015889A (ko) 2003-02-25
IL153988A (en) 2006-10-05
PL364439A1 (en) 2004-12-13
AR032358A1 (es) 2003-11-05
CN100509791C (zh) 2009-07-08
WO2002008216A1 (en) 2002-01-31
CN1662519A (zh) 2005-08-31
SK2022003A3 (en) 2003-06-03

Similar Documents

Publication Publication Date Title
BRPI0312464B8 (pt) compostos inibidores de tirosina quinases, composições farmacêuticas compreendendo os mesmos, processos para fabricação e usos dos mesmos
BR0215240A (pt) Derivados de calcona e seu uso no tratamento de doenças
BR0212344A (pt) Composto, processo para preparar um composto, uso de um composto, método para produzir um efeito inibidor de ácido de bile ileal em um animal de sangue quente e composição farmacêutica
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
BRPI0417708A (pt) derivados organofosfóricos dos indazóis e sua utilização como inibidores das proteìnas quinases
BR0312280A (pt) Composto ou um sal, solvato, solvato de tal sal ou uma prodroga do mesmo faarmaceuticamente aceitável, processo para prepará-lo, composição farmacêutica, uso do composto, métodos para produzir um efeito inibidor da absorção de colesterol, e para tratar condições hiperlipidêmicas em um animal de sangue quente, tal como o homem, que necessita de tal tratamento, combinação, e, uso desta
BR9502707A (pt) Composto composição farmacêutica e método para o tratamento de uma afecção
BRPI0417376A (pt) compostos, processo para a manufatura dos mesmos, composições farmacêuticas que os compreendem, método para o tratamento e/ou profilaxia de enfermidades que estão associadas com a modulação de receptores de cb1 e sua utilização
BR0312957A (pt) Composto ou um sal farmaceuticamente aceitável deste, uso do mesmo, composição farmacêutica, e, método para produzir um efeito inibidor de 11betahsd1 em um animal de sangue quente, tal como o homem, em necessidade de tal tratamento
BR0116397A (pt) Composto, processo para preparar o mesmo, uso de um composto, método para produzir um efeito inibidor de ibat em um animal de sangue quente, e, composição farmacêutica
BRPI0409916A (pt) ácidos carboxìlicos substituìdos com fenila
BRPI0317463B8 (pt) composto, composição farmacêutica compreendendo o mesmo e uso do referido composto no preparo de um medicamento para tratar uma doença amilóide de transtiretina
BRPI0415613A (pt) novos compostos de diazaspiroalcanos e seu uso no tratamento de doenças mediadas por ccr8
BRPI0409109A (pt) novos compostos
BR9810592A (pt) Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto
BRPI0512974A (pt) novos derivados de hidantoìna para o tratamento de doenças obstrutivas das vias aéreas
AR024197A1 (es) Compuesto derivado de succinamida, composicion farmaceutica que lo comprende y uso de dicho compuesto en la fabricacion de un medicamento util para eltratamiento de afecciones neurologicas
BR0113011A (pt) Novos compostos e sua utilização como inibidores de transporte de glicina; composição farmacêutica e método do tratamento
BR0315580A (pt) Derivados de metileno uréia
BRPI0607583A2 (pt) derivados de piridin-2-carboxamida como antagonistas mglur5, método para sua preparação, medicamento contendo os mesmos, bem como uso relacionado aos referidos compostos
BR9612423A (pt) Composto, composição farmacêutica, e, processo para tratar um estado doentio.
BRPI0409498A (pt) uso de um composto, formulação farmacêutica, composto, composição farmacêutica, e, processo para preparação de um composto
BR0312000A (pt) Compostos, composições farmacêuticas, método para o tratamento ou profilaxia de doenças, e, uso dos compostos
BR0316629A (pt) Uréias e carbamatos substituìdos

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7O E 8O ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 NA RPI 2021 DE 29/09/2009.